On particles of different doses of treatment of vertebral Yangxueqingnao - basilar artery insufficiency vertigo observation.docVIP

On particles of different doses of treatment of vertebral Yangxueqingnao - basilar artery insufficiency vertigo observation [Keywords:] Yangxueqingnao particles, vertebral - basilar artery insufficiency, vertigo Vertebral - basilar artery insufficiency (VBI) vertigo is common in the elderly. I used different doses of VBI Yangxueqingnao Treatment of 64 patients with vertigo, the clinical efficacy of transcranial Doppler (TCD) of the changes were observed, the results reported below. 1 Materials and Methods 1.1 The inclusion criteria VBI diagnostic use [1] criteria: ① The chief complaint of vertigo, ② both transient ischemia and other brain stem symptoms, such as eye symptoms (amaurosis, flash, visual distortion, diplopia, etc.), ear pain, numbness or weakness, cataplexy, syncope, ③ slight signs of changing the brain stem damage, such as the corneal reflex / gag reflex reduced or lost, conditioning / vergence disorders, vertebral artery compression after spontaneous or induced nystagmus, the pathological positive so, ④ clear etiology, ⑤ vertigo caused by the exclusion of other disorders, including head CT / MRI examination was normal. symptomatology grade criterion-referenced lt;lt;Chinese new drug clinical research guidelines, “[2], according to the degree of severity of vertigo patients were divided into light , moderate, and severe three levels. 1.2 General Information Meet the above diagnostic criteria, 64 patients from the hospital neurology. Randomly divided into 2 groups. 33 cases of high-dose group, 15 males and 18 females, aged 52 to 74 years, mean 64 years, 9 patients with mild , 12 cases of moderate and severe in 12 cases. 31 patients in the conventional dose group, 11 males and 20 females, aged 53 to 72 years, mean 64-year-old, mild in 7 cases, moderate in 13 cases, 11 cases of severe .2 patients age, sex, level of vertigo by the statistical analysis, no statistical significance (Pgt; 0.05), comparable. 1.3 Treatment 2 groups w